GERD May Increase Risk for Subsequent Non–Small Cell Lung Cancer
Investigators studied the association between gastroesophageal reflux disease and non–small lung cancer in a retrospective case-control study.
Gastroesophageal Reflux Disease (GERD)
Proton Pump Inhibitor Use May Decrease Urinary Citrate Excretion
A reduction in urinary citrate levels may be the mechanism underlying the higher incidence of kidney stones in patients taking PPIs, according to investigators.
Increased GERD Risk in End-Stage Lung Disease Without Esophageal Disease
End-stage lung disease may significantly increase the risk for gastroesophageal reflux disease (GERD) in patients undergoing lung transplant without primary esophageal disease.
Clinical Program for Investigational GERD Drug Discontinued
The bile acid sequestrant was designed to be maintained in the stomach over an extended period of time where it was expected to intercept bile before it reached the esophagus.
Proton Pump Inhibitor Use Linked to Increased T2D Risk
Regular use of proton pump inhibitors is associated with an increased risk for type 2 diabetes.
Acid Reflux Monitoring May Indicate Candidates for PPI Discontinuation in Those With Typical Reflux Symptoms
Acid exposure measured via reflux monitoring can be predicative of a patient’s ability to discontinue PPI use without symptom escalation.
PPI Use Is Negative Prognostic Marker in Urothelial Cancer
For patients with advanced urothelial cancer treated with atezolizumab, proton pump inhibitor use is a negative prognostic marker.
Coffee, Tea, Soda Tied to Higher Risk for Gastroesophageal Reflux
Coffee, tea, and soda are associated with an increased risk for gastroesophageal reflux symptoms among middle-aged women.
Sleeve Gastrectomy Linked to High Prevalence of Barrett Esophagus
Patients undergoing sleeve gastrectomy sometimes develop gastroesophageal reflux disease, a major risk factor for Barrett’s esophagus; therefore, researchers investigated whether patients with SG have a high rate of BE.
Peroral Endoscopic Myotomy Safe, Effective in Patients on Antithrombotics
Investigators sought to determine whether peroral endoscopic myotomy is safe in patients receiving antithrombotic therapy and examined its clinical success and postprocedural rates of GERD.
-
Loading...
-
Loading...
Next post in General Gastroenterology
